Epilepsy trials in Poland

In Poland 18 Also abroad 451

18 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 3Taking people
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Where
Krakow, Poznan
Age
4 years to 55 years
People
252 worldwide
Run by
SK Life Science, Inc.
See details and how to joinNCT05219617
Phase 3Taking people
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Where
Bydgoszcz, Gdansk, Katowice, Nowa Sol
Age
12 years and over
People
160 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05667142 · EU 2022-502286-16-00
Phase 3Taking people
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Where
Gdansk, Nowa Sol, Warsaw
Age
18 years and over
People
360 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05716100 · EU 2022-502281-25-00
Phase 3Enrolling by invitation
An Open-label Study of XEN1101 in Epilepsy
Where
Bydgoszcz, Gdansk, Katowice, Lublin, Nowa Sol, Warsaw, Warszawa
Age
12 years and over
People
880 worldwide
Run by
Xenon Pharmaceuticals Inc.
See details and how to joinNCT05718817 · EU 2022-502282-24-00
Phase 3Taking people
Open Label Extension Clinical Trial of Vormatrigine in Adult Patients with Epilepsy.
Where
Bydgoszcz, Katowice, Lublin, Warsaw
Age
18 years and over
People
56 worldwide
Run by
Praxis Precision Medicines Inc.
See details and how to join2025-521640-38-00 · EU 2025-521640-38-00
Phase 3Taking people
A Study of EPX-100 (Clemizole Hydrochloride) in Participants With Dravet Syndrome
Where
Gdansk, Krakow, Warsaw
Age
2 years and over
People
150 worldwide
Run by
Epygenix
See details and how to joinNCT04462770 · EU 2024-518628-57-00
Phase 2Enrolling by invitation
SPN-817 Open-Label Extension Study in Adults With Focal Onset Seizures
Where
DO NOT EDIT
Age
18 years and over
People
100 worldwide
Run by
Supernus Pharmaceuticals, Inc.
See details and how to joinNCT07141329 · EU 2026-526361-15-00
Phase 2/3Taking people
Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in Infants
Where
Lodz, Warsaw
Age
4 weeks to 16 weeks
People
60
Run by
Katarzyna Kotulska
See details and how to joinNCT04987463 · EU 2024-513068-25-00
Phase 3Taking people
Placebo Controlled Study to Assess the Efficacy and Safety of Rapamycin in Drug Resistant Epilepsy Associated With Tuberous Sclerosis Complex
Where
Lodz, Warsaw
Age
3 months to 50 years
People
200
Run by
Katarzyna Kotulska
See details and how to joinNCT05534672 · EU 2024-515937-13-00
Phase 3Taking people
Efficacy and Safety Study of Once-Daily Extended-Release Levetiracetam in Drug-resistant Focal Onset Seizures
Where
Cracow, Gdansk, Lublin, Pruszkow, Warsaw
People
134 worldwide
Run by
Neuraxpharm Pharmaceuticals S.L.
See details and how to join2024-514499-42-00 · EU 2024-514499-42-00
Phase 3Taking people
An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome
Where
Krakow, Warsaw, Wroclaw
Age
2 years to 55 years
People
260 worldwide
Run by
Epygenix
See details and how to joinNCT05066217
Phase 2Taking people
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Where
Gdynia, Katowice, Krakow, Lublin, Sopot, Warsaw
Age
18 years to 70 years
People
216 worldwide
Run by
Supernus Pharmaceuticals, Inc.
See details and how to joinNCT06798896
Phase 2Taking people
SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset Seizures
Where
Cracow, Gdynia, Katowice, Lublin, Mikolow, Sopot, Warsaw
Age
18 years and over
People
110 worldwide
Run by
Supernus Pharmaceuticals Inc.
See details and how to join2025-520587-18-00 · EU 2025-520587-18-00
Phase 3Enrolling by invitation
Clinical Trial of Vormatrigine in Adult Patients With Epilepsy
Where
Bydgoszcz, Katowice, Lublin, Warsaw
Age
18 years to 85 years
People
700 worldwide
Run by
Praxis Precision Medicines
See details and how to joinNCT07287163
Phase 3Taking people
A Study to Test the Safety and Tolerability of Brivaracetam in Children and Adolescents With Seizures
Where
Kielce, Krakow, Poznan
Age
1 month and over
People
70 worldwide
Run by
UCB Biopharma SRL
See details and how to joinNCT04715646
Phase 2Enrolling by invitation
Long-term Safety and Tolerability of BHV-7000
Where
Cracow, Gdansk, Katowice, Krakow, Lodz, Lublin, Nowa Sol, Poznan, Świdnik, Warsaw, Wroclaw, Wrocław
Age
18 years to 75 years
People
660 worldwide
Run by
Biohaven Therapeutics Ltd.
See details and how to joinNCT06443463 · EU 2023-508813-18-00
Phase 3Taking people
TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders
Where
Warsaw
Age
2 years to 30 years
People
40 worldwide
Run by
Meyer Children's Hospital IRCCS
See details and how to joinNCT07377032
Phase 3Taking people
Study of Oral MC-1 for the Treatment of Patients with PNPO Deficiency
Where
Gdansk, Lodz, Wroclaw
People
3
Run by
Medicure International Inc.
See details and how to join2025-522346-46-00 · EU 2025-522346-46-00